Altamira Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
11 Mar 24 | BuyUS$32,436 | Thomas Meyer | Individual | 17,401 | US$3.24 |
Insider Trading Volume
Insider Buying: CYTO insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,660 | 0.0741% |
Institutions | 2,176 | 0.0971% |
Individual Insiders | 20,692 | 0.924% |
General Public | 2,215,717 | 98.9% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 541.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
20,000 | US$29.8k | 669% | no data | |||
2,261 | US$3.4k | -0.04% | no data | |||
1,660 | US$2.5k | 95.1% | no data | |||
279 | US$415.6 | 0.36% | no data | |||
278 | US$414.2 | 27,700% | no data | |||
103 | US$153.5 | 0% | no data | |||
32 | US$47.7 | 0% | no data | |||
14 | US$20.7 | 0% | no data | |||
1 | US$1.3 | 0% | no data |